Home › Companies › AngioDynamics, Inc. › 2024-2025
Compiled from SEC Form N-PX filings and AngioDynamics, Inc.’s Form 8-K, filed 2024-11-15 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore AngioDynamics, Inc. in the interactive database Compare manager voting policies
These tallies are AngioDynamics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-11-15 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Lorinda A. Burgess | 26,292,870 | -- | -- | 1,996,095 | 5,993,164 | Majority: yes |
| Elect Director: Wesley E. Johnson, Jr. | 24,817,356 | -- | -- | 3,471,609 | 5,993,164 | Majority: yes |
| Elect Director: Karen A. Licitra | 26,276,748 | -- | -- | 2,012,217 | 5,993,164 | Majority: yes |
| Proposal 2: The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2025 was approved based upon the following votes: | 34,110,530 | 155,077 | 16,522 | -- | -- | Majority: yes |
| Proposal 3: The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers was approved based upon the following votes: | 26,004,908 | 1,248,479 | 1,035,578 | -- | 5,993,164 | Majority: yes |
| Proposal 4: The proposal to approve the amended AngioDynamics, Inc. 2020 Equity Incentive Plan was approved based upon the following votes: | 23,195,346 | 5,058,468 | 35,151 | -- | 5,993,164 | Majority: yes |
Source: AngioDynamics, Inc., Form 8-K, filed with the SEC on 2024-11-15 — read the filing on EDGAR.
Each item below shows how the 157 asset managers that disclosed a AngioDynamics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Proposal 3: The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers was approved based upon the following votes:”): 26,004,908 for, 1,248,479 against, per its Form 8-K filed 2024-11-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 41,004,249 outstanding shares: 63% for, 3% against (66% of the company cast a for/against vote).
The 152 asset managers below cast 97% of the shares they voted on this item FOR (25,165,250 for, 796,449 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,030,931 | 0 | 0 | 0 | For |
| Vanguard | 2,286,182 | 0 | 0 | 0 | For |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 1,370,954 | 12,060 | 0 | 0 | For |
| Dimensional | 1,296,096 | 0 | 0 | 0 | For |
| Fidelity | 1,036,198 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 967,940 | 0 | 0 | 0 | For |
| Royce | 966,073 | 0 | 0 | 0 | For |
| Nuveen | 943,296 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 892,302 | 0 | 0 | 0 | For |
| Renaissance | 777,346 | 0 | 0 | 0 | For |
| State Street | 759,560 | 0 | 0 | 0 | For |
| Two Sigma | 717,026 | 0 | 0 | 0 | For |
| Charles Schwab | 660,260 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 450,922 | 0 | 0 | Against |
| SEGALL BRYANT & HAMILL, LLC | 432,785 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 384,614 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Northern Trust | 343,402 | 0 | 0 | 0 | For |
| Orion Porfolio Solutions, LLC | 337,824 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| JPMorgan | 315,488 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 275,048 | 0 | 0 | 0 | For |
| Point72 | 273,325 | 0 | 0 | 0 | For |
| DE Shaw | 234,409 | 0 | 0 | 0 | For |
Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Proposal 4: The proposal to approve the amended AngioDynamics, Inc. 2020 Equity Incentive Plan was approved based upon the following votes:”): 23,195,346 for, 5,058,468 against, per its Form 8-K filed 2024-11-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 41,004,249 outstanding shares: 57% for, 12% against (69% of the company cast a for/against vote).
The 54 asset managers below cast 87% of the shares they voted on this item FOR (8,985,968 for, 1,355,978 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 0 | 941,141 | 0 | 0 | Against |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 216,951 | 0 | 0 | Against |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 71,365 | 63,700 | 0 | 0 | For |
| Invesco | 100,828 | 0 | 0 | 0 | For |
| Manatuck Hill Partners, LLC | 96,097 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,727 | 30,192 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 0 | 52,879 | 0 | 0 | Against |
| Voya | 42,267 | 0 | 0 | 0 | For |
| Putnam | 0 | 31,987 | 0 | 0 | Against |
| ADVISORS' INNER CIRCLE FUND | 27,779 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,108 | 0 | 0 | 0 | For |
| Northern Trust | 26,566 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 4 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Elect Director: Karen A. Licitra”): 26,276,748 for, 2,012,217 withheld, per its Form 8-K filed 2024-11-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 41,004,249 outstanding shares: 64% for, 5% withheld (69% of the company cast a for/withheld vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,286,282 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 216,951 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 135,065 | 0 | 0 | 0 | For |
| Invesco | 100,828 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,919 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 52,879 | 0 | 0 | 0 | For |
| Voya | 42,267 | 0 | 0 | 0 | For |
| GuideStone | 40,606 | 0 | 0 | 0 | For |
| Putnam | 31,987 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 27,779 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,108 | 0 | 0 | 0 | For |
| Northern Trust | 26,566 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 4 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Elect Director: Lorinda A. Burgess”): 26,292,870 for, 1,996,095 withheld, per its Form 8-K filed 2024-11-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 41,004,249 outstanding shares: 64% for, 5% withheld (69% of the company cast a for/withheld vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,286,282 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 216,951 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 135,065 | 0 | 0 | 0 | For |
| Invesco | 100,828 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,919 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 52,879 | 0 | 0 | 0 | For |
| Voya | 42,267 | 0 | 0 | 0 | For |
| GuideStone | 40,606 | 0 | 0 | 0 | For |
| Putnam | 31,987 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 27,779 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,108 | 0 | 0 | 0 | For |
| Northern Trust | 26,566 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 4 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Elect Director: Wesley E. Johnson, Jr.”): 24,817,356 for, 3,471,609 withheld, per its Form 8-K filed 2024-11-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 41,004,249 outstanding shares: 61% for, 8% withheld (69% of the company cast a for/withheld vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,071,338 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 216,951 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 135,065 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 100,828 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 0 | 0 | 83,500 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,919 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 52,879 | 0 | 0 | 0 | For |
| Voya | 42,267 | 0 | 0 | 0 | For |
| GuideStone | 40,606 | 0 | 0 | 0 | For |
| Putnam | 31,987 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 0 | 0 | 27,779 | 0 | Abstain |
| Goldman Sachs | 27,108 | 0 | 0 | 0 | For |
| Northern Trust | 26,566 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
AngioDynamics, Inc.’s own tally for this item (“Proposal 2: The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2025 was approved based upon the following vo”): 34,110,530 for, 155,077 against, per its Form 8-K filed 2024-11-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 41,004,249 outstanding shares: 83% for, 0.4% against (84% of the company cast a for/against vote).
The 52 asset managers below cast 99.9% of the shares they voted on this item FOR (10,286,282 for, 143 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 216,951 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 135,065 | 0 | 0 | 0 | For |
| Invesco | 100,828 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,919 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 52,879 | 0 | 0 | 0 | For |
| Voya | 42,267 | 0 | 0 | 0 | For |
| GuideStone | 40,606 | 0 | 0 | 0 | For |
| Putnam | 31,987 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 27,779 | 0 | 0 | 0 | For |
| Goldman Sachs | 27,108 | 0 | 0 | 0 | For |
| Northern Trust | 26,566 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Ranked by the number of AngioDynamics, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 41,004,249 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 9.83% |
| 2 | Vanguard | 5.58% |
| 3 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 3.37% |
| 4 | Dimensional | 3.16% |
| 5 | Fidelity | 2.53% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.36% |
| 7 | Royce | 2.36% |
| 8 | Nuveen | 2.30% |
| 9 | TIAA | 2.30% |
| 10 | ARMISTICE CAPITAL, LLC | 2.18% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 8.77% | 13F |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 6.12% | 13G |
| Vanguard Group | 6.08% | 13F |
| KEVIN KOTLER | 5.91% | 13G |
| Integrated Core Strategies (US) LLC | 5.18% | 13G |
| Armistice Capital, LLC | 3.73% | 13G |
| Nuveen | 3.16% | 13F |
| Millennium Management | 3.02% | 13F |
| Dimensional Fund Advisors | 2.84% | 13F |
| James C. Clemmer | 2.73% | DEF14A |
Percentages above are of 41,004,249 shares outstanding, as reported by AngioDynamics, Inc. on its Form 10-Q dated 2024-08-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AngioDynamics, Inc.’s 10-Q dated 2024-08-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At AngioDynamics, Inc.'s shareholder meeting held 2024-11-12, in the 2024-2025 proxy season, 157 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,142 separate fund positions. On the most widely held item on that ballot — Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AngioDynamics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-11-15.
AngioDynamics, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.